Allosteric regulation of binding and function at GPCRS

Medicinal Chemistry Research

Volumn 13, Issue 1-2, 2004, Pages 52-62

  Birdsall, Nigel J M ^a   Browning, Christopher ^a   Hern, Jonathan ^a   Lazareno, Sebastian ^b  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; 2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; AC 42; ACETYLCHOLINE; ALCURONIUM; ANTIOXIDANT; BRUCINE; G PROTEIN COUPLED RECEPTOR; KT 5720; METHYLSCOPOLAMINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PG 987; PILOCARPINE; WIN 35 577; WIN 62577;

ALLOSTERISM; ALZHEIMER DISEASE; BINDING AFFINITY; COMPLEX FORMATION; CONFERENCE PAPER; DISSOCIATION; DRUG BINDING; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HORMONE RELEASE; ISOMERIZATION; MOLECULAR MECHANICS; MOLECULAR MODEL; NEUROTRANSMITTER RELEASE; PARKINSON DISEASE; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 7044236957     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-004-0009-7     Document Type: Conference Paper

References (47)

1. Kenakin, T. Nat. Rev. Drug Discov. 2002, 31, 103-110.
2. Soudijn, W. S.; Van Wijngaarden, I.; Ijzermann, A. P. Curr. Opin. Drug Discov. Devel. 2002, 5, 749-755.
3. Christopoulos, A.; Kenakin, T. Pharmacol. Rev. 2002, 54, 323-374.
4. Lullmann, H.; Ohnesorge, F. K.; Schauwecker, G. C.; Wassermann, O. Eur. J. Pharmacol. 1969, 6, 241-247.
5. Clark, A. L.; Mitchelson, F. Br. J. Pharmacol. 1976, 58, 323-331.
6. Stockton, J.M.; Birdsall, N. J. M.; Burgen, A. S. V.; Hulme, E. C. Mol. Pharmacol. 1983, 23, 551-557.
7. Ehlert, F. J. Mol. Pharmacol. 1988, 35, 187-194.
8. Tuček, S.; Proška, J. Trends Pharmacol. Sci. 1995, 16, 205-212.
9. Birdsall, N. J.M.; Lazareno, S.; Matsui, H. Prog. Brain Res. 1996, 109, 147-151.
10. Ellis, J. Drug Development Res. 1997, 40, 193-204.
11. Holzgrabe, U.; Mohr, K. Drug Discovery Today 1998, 3, 214-222.
12. Lazareno, S.; Birdsall, N. J. M. Mol. Pharmacol. 1995, 48, 362-378.
13. Lazareno, S.; Gharagozloo, P.; Kuonen, D.; Popham, A.; Birdsall, N. J. M. Mol. Pharmacol. 1998, 53, 573-589.
14. Birdsall, N.J.M.; Fairies, T.; Gharagozloo, P.; Kobayashi, S.; Lazareno, S.; Sugimoto, M. Mol. Pharmacol. 1999, 55, 778-786.
15. Gharagozloo, P.; Lazareno, S.; Miyauchi, M.; Popham, A.; Birdsall, N. J. M. J. Med. Chem. 2002, 45, 1259-1274.
16. Lazareno, S.; Birdsall, B.; Fukazawa, T.; Gharagozloo, P.; Hashimoto, T.; Kuwano, H.; Popham. A.; Sugimoto. M.; Birdsall, N. J. M. Life Sci. 1999, 64, 519-526.
17. Lazareno, S.; Popham, A.; Birdsall, N. J. M. Mol. Pharmacol. 2000, 58, 194-207.
18. Lazareno, S.; Popham, A.; Birdsall, N. J. M. Mol. Pharmacol. 2002. 62, 1492-1505.
19. Leppik, R.A.; Lazareno, S.; Mynett, A.; Birdsall, N. J. M. Mol. Pharmacol. 1998, 53, 916-925.
20. Leppik, R.A.; Mynett, A.; Lazareno, S.; Birdsall, N. J. M . Mol. Pharmacol. 2000, 57, 436-445
21. Leppik, R.A.; Birdsall, N. J. M. Mol. Pharmacol. 2000, 58, 1091-1099.
22. Cohen, F.; Lazareno, S.; Birdsall, N. J. M. Brit. J. Pharmacol. 1994, 113, 51P.
23. Tränkle, C.; Mies-Klomfass, E.; Cid, M. H.; Holzgrabe, U.; Mohr, K.. Mol. Pharmacol. 1998, 54, 139-145.
24. Trankle, C.; Weyand, O.; Schröter, A.; Mohr, K. Mol. Pharmacol. 1999, 56, 962-965.
25. Trankle, C.; Weyand, O.; Voigtländer, U.; Mynett, A.; Lazareno, S.; Birdsall, N. J. M.; Mohr, K. Mol. Pharmacol. 2003, 64, 180-190.
26. Browning, C.; Beresford, I. J. M.; Sheehan, M. J.; Birdsall, N. J. M. Br. J. Pharmacol. 2000, 131, 36P
27. De Lean, A.; Stadel, J. M.; Lefkowitz, R. J. J. Biol. Chem. 1980, 255, 7108-7117.
28. Hall, D. A. Mol. Pharmacol. 2000, 58, 1412-1423.
29. Parmentier, M-L.; Prezeau, L.; Bockaert, J.; Pin, J-P. Trends Pharmacol. Sci. 2002, 23, 268-274.
30. Leeb-Lundberg, L. M.; Mathis, S. A. J. Biol. Chem. 1990 265, 9621-9627.
31. Samama, P.; Cotecchia, S.; Costa, T.; Lefkowitz, R. J. J. Biol. Chem. 1993, 268, 4625-4636.
32. Caulfield, M. P.; Birdsall, N. J. M. Pharmacol. Rev. 1998, 50, 279-290.
33. Eglen, R. M.; Watson, N. Pharmacol. Toxicol. 1996, 78, 59-78.
34. Eglen, R. M.; Nahorski, S. R. Br. J. Pharmacol. 2000, 130, 13-21.
35. Lu, Z. L.; Saldanha, J. W.; Hulme, E. C. Trends Pharmacol. Sci. 2002, 23, 140-146.
36. Lazareno, S.; Dolezal, V.; Popham, A.; Birdsall, N. J. M. Submitted for publication.
37. Ellis, J.; Seidenberg, M. Mol. Pharmacol. 1992, 42, 638-641.
38. Waelbroeck, M. Mol. Pharmacol. 1994, 46, 685-692.
39. Lanzafame, A.; Christopoulos, A.; Mitchelson, F. J. Pharmacol. Exp. Ther. 1997, 282, 278-285.
40. Lazareno, S.; Popham, A.; Birdsall, N. J .M. Mol. Pharmacol. 2002, 58, 198-207.
41. Lazareno, S.; Popham, A.; Birdsall, N. J. M. Mol. Pharmacol. 2002, 62, 1492-1505.
42. Lazareno, S.; Popham, A.; Birdsall, N. J. M. J. Mol. Neurosci. 2003, 20, 363-367.
43. Bruns, R. F.; Fergus, J. H. Mol. Pharmacol. 1990, 38, 939-949.
44. Birdsall, N. J. M.; Burgen, A. S. V.; Hulme, E. C.; Zigmond, M. J. 1981, Brit. J. Pharmacol. 142-143.
45. Spalding, T. A.; Burstein, E. Mol. Pharmacol. 2001, 1297-1302.
46. Zahn, K.; Eckstein, N.; Tränkle, C.; Sadee, W.; Mohr, K. J. Pharmacol. Exp. Ther. 2002, 301, 720-728.
47. Proaka, J.; Tucek, S. Mol. Pharmacol. 1994, 709-717.